Literature DB >> 1638554

An extract of seeds from Aeginetia indica L., a parasitic plant, induces potent antigen-specific antitumor immunity in Meth A-bearing BALB/c mice.

J G Chai1, T Bando, S Kobashi, M Oka, H Nagasawa, S Nakai, K Maeda, K Himeno, M Sato, S Ohkubo.   

Abstract

The antitumor activity of an extract of seeds from Aeginetia indica L., a parasitic plant, was investigated. BALB/c mice, inoculated i.p. 1 x 10(5) syngeneic Meth A tumor cells, were administered 2.5 mg/kg A. indica extract i.p. every 2 days from day 0. The untreated mice died of an ascitic form of tumor growth within 21 days, whereas all the treated mice completely recovered from tumor challenge without any side-effects. The extract did not exert direct cytotoxic activity against Meth A in vitro. Mice that survived after the first challenge as a result of A. indica treatment overcame the rechallenge with homologous Meth A without additional administration of the extract. On the other hand, those mice could not survive after rechallenge with Meth 1 tumor cells, which were also established in BALB/c mice but were different in antigenicity from Meth A, suggesting the development of antigen-specific concomitant immunity in the A. indica-cured mice. In the induction phase of antitumor resistance in this system, CD4+ T cells appeared to be the main contributors, since in vivo administration of anti-CD4 mAb completely abolished such resistance. In contrast, anti-CD8 mAb administration did not influence the effect of A. indica. The importance of CD4+ T cells in antitumor immunity was again clarified by Winn assay; that is, spleen and lymph node cells depleted of CD4+ T cells in vitro prior to assay abolished antitumor activity on co-grafted Meth A tumor cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638554     DOI: 10.1007/bf01756185

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  16 in total

1.  Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts.

Authors:  H J WINN
Journal:  J Immunol       Date:  1961-02       Impact factor: 5.422

2.  Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.

Authors:  K Gomi; M Morimoto; K Nomoto
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

3.  Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.

Authors:  M A Cheever; P D Greenberg; C Irle; J A Thompson; D L Urdal; D Y Mochizuki; C S Henney; S Gillis
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

4.  Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.

Authors:  J A Thompson; D J Peace; J P Klarnet; D E Kern; P D Greenberg; M A Cheever
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

5.  Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.

Authors:  P D Greenberg
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

6.  Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.

Authors:  T Chou; S Shu
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

7.  Characterization of T lymphocytes mediating in vivo protection against RSV-induced murine sarcomas.

Authors:  M Prat; M F Di Renzo; P M Comoglio
Journal:  Int J Cancer       Date:  1983-06-15       Impact factor: 7.396

8.  The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.

Authors:  H Fujiwara; M Fukuzawa; T Yoshioka; H Nakajima; T Hamaoka
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

9.  Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.

Authors:  P D Greenberg; D E Kern; M A Cheever
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  4 in total

1.  Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.

Authors:  Masato Okamoto; Go Oh-E; Tetsuya Oshikawa; Sachiko Furuichi; Tomoyuki Tano; Sharif U Ahmed; Sachiko Akashi; Kensuke Miyake; Osamu Takeuchi; Shizuo Akira; Kunisuke Himeno; Mitsunobu Sato; Shinya Ohkubo
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

2.  Effects of a Chinese Herbal Medicine, Guan-Jen-Huang (Aeginetia indica Linn.), on Renal Cancer Cell Growth and Metastasis.

Authors:  Yu-Huei Liu; Meng-Luen Li; Meng-Yu Hsu; Ya-Yueh Pang; I-Ling Chen; Ching-Kuei Chen; Sai-Wen Tang; Hsuan-Yuan Lin; Jung-Yaw Lin
Journal:  Evid Based Complement Alternat Med       Date:  2011-10-18       Impact factor: 2.629

3.  Aeginetia indica Decoction Inhibits Hepatitis C Virus Life Cycle.

Authors:  Cheng-Wei Lin; Chieh-Wen Lo; Chia-Ni Tsai; Ting-Chun Pan; Pin-Yin Chen; Ming-Jiun Yu
Journal:  Int J Mol Sci       Date:  2018-01-09       Impact factor: 5.923

4.  Sequential T cell response involved in tumor rejection of sarcoma, Meth A, in syngeneic mice.

Authors:  Y Jiao; S Fujimoto
Journal:  Jpn J Cancer Res       Date:  1998-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.